I

Iterum Therapeutics plc

23 employees

Iterum Therapeutics is a clinical-stage pharmaceutical company that develops significantly differentiated anti-infectives.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Therapeutics
Medical
Pharmaceutical

Date founded

2015

Funding rounds raised

Total raised

$65M

from 15 investors over 15 rounds

I

Iterum Therapeutics plc raised $52M on January 17, 2020

Investors: RA Capital Management, L.P.

I

Iterum Therapeutics plc raised $1.5M on July 1, 2017

Investors: CARB-X

I

Iterum Therapeutics plc raised $65M on May 19, 2017

Investors: Domain Associates, Arix Bioscience plc, Sofinnova Ventures, Russia technology fund, Advent Life Sciences, Canaan, Frazier Healthcare Partners, Bay City Capital and New Leaf Venture Partners

I

Iterum Therapeutics plc raised $40M on March 24, 2016

Investors: New Leaf Venture Partners, Sofinnova Ventures, Russia technology fund, Canaan and Frazier Healthcare Partners

I

Iterum Therapeutics plc raised undisclosed on January 1, 2015

Investors: Sofinnova Ventures, Russia technology fund

FAQ